Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 771 across all filing types
Latest filing 2021-03-02 Director's Dealing
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Zawiadomienie J.Bogdańska
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). It details a transaction involving a person discharging managerial responsibilities ('PRZEWODNICZĄCA RADY NADZORCZEJ' - Chairperson of the Supervisory Board) concerning the company's financial instruments (subscription warrants). This structure and content directly correspond to insider trading disclosures mandated by market abuse regulations (MAR). Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate category for reporting personal share transactions by company directors and executives (insider trades).
2021-03-02 Polish
Otrzymanie zawiadomień, o którym mowa w art. 19 ust. 1 MAR - Content (PL)
Director's Dealing Classification · 100% confidence The document text is very short (444 characters) and explicitly states that notifications received under Article 19(1) of the MAR Regulation (which concerns transactions by persons discharging managerial responsibilities - PDMRs) are attached to the report. This structure—announcing the receipt of insider transaction notifications and stating they are attached—is characteristic of a Director's Dealing report, which in the provided schema corresponds to the 'DIRS' code. Although it is an announcement, the core subject matter is the director's dealing, making DIRS more specific than RPA or RNS.
2021-03-02 Polish
Harmonogram publikacji raportów okresowych w roku 2021 - Content (PL)
Report Publication Announcement Classification · 100% confidence The document text, written in Polish, explicitly lists the dates for the release of periodic reports (annual, quarterly, and semi-annual) for the year 2021. It states: 'Zarząd Medinice S.A. (Spółka) niniejszym podaje do publicznej wiadomości daty przekazywania raportów okresowych w roku 2021' (The Management Board of Medinice S.A. hereby announces the dates for the submission of periodic reports in 2021). This is not the report itself, but an announcement about *when* the reports will be published. According to Rule #2, a document announcing the publication of reports falls under Report Publication Announcement (RPA).
2021-01-20 Polish
Zawarcie przedwstępnej umowy kupna udziałów w Spółce posiadającej prawa do opatentowanej technologii kardiochirurgicznej - Content (PL)
M&A Activity Classification · 99% confidence The document describes a preliminary agreement entered into by the Issuer (Emitent) to purchase shares in a Polish limited liability company that owns patented surgical technology. The transaction involves cash payment, issuance of warrants, and capital increase. This clearly details a significant corporate transaction involving the acquisition of assets/equity, which falls under the category of Mergers & Acquisitions (M&A) activity or a major financing/capital structure change. Given the focus on acquiring another entity's shares and technology, the most appropriate classification is M&A Activity (TAR). It is not a standard earnings release (ER), interim report (IR), or a simple announcement of a report (RPA/RNS), as it contains substantive details about the deal structure and underlying asset.
2021-01-06 Polish
Podpisanie z NCBiR umowy o dofinansowanie rozwoju elektrody EP Bioptom - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a short announcement (947 characters) from the Management Board (Zarząd) of Medinice S.A. It references a previous filing and details the receipt of a signed co-financing agreement from the National Centre for Research and Development (NCBiR) for a specific project ('EP Bioptom'). This concerns funding, grants, and project development, which falls under financing activities or capital structure changes. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it details the securing of significant funding (dofinansowanie) for a project. It is not a full report, an earnings release, or a standard regulatory filing (RNS), but a specific announcement about securing funds.
2020-12-30 Polish
Wyznaczenie pierwszego dnia notowań na Głównym Rynku GPW - Content (PL)
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement from the Management Board of Medinice S.A. regarding resolutions passed by the GPW (Warsaw Stock Exchange) management board. These resolutions concern the admission and introduction of several series of the company's common shares to trading on the main market, effective December 30, 2020. It also mentions the exclusion of the company's shares from the NewConnect alternative trading system. This action directly relates to changes in the company's capital structure and the listing status of its shares. This fits best under 'Capital/Financing Update' (CAP) as it details the admission of new shares to the main market, or potentially 'Share Issue/Capital Change' (SHA). Given the focus is on the admission/introduction to trading following a decision, and it involves a significant change in the capital structure's listing venue, CAP is a strong fit, although SHA is also relevant. Since it details the admission of specific series of shares to the main market, which is a capital market event, I will classify it as CAP (Capital/Financing Update). The document is short and is an announcement, not a full report.
2020-12-28 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.